More Post from the Author
- AutoMobility LA 2025
- Radiate Holdco, LLC Releases Third Quarter 2025 Financial Results
- Workshop Debuts Four New AI Features, Positioning Itself as the Clear Leader in AI for Internal Communications
- r4 Technologies Donates Smart Food AI Program to Help States Feed SNAP Beneficiaries
- Armor Health's Data Driven Approach to Patient Care Helps Secure Agreement to Provide Correctional Healthcare Service for Inmates in Bell County Texas
QuantalX Neuroscience Announces CE MDR Approval, Making Brain Health Assessment Available in the EU
Published on Wed 12 Feb 2025 8:06:56 UTC
The company announces CE MDR approval for its novel Delphi-MD neurodiagnosis medical device in preparation for EU commercialization, improving patients' clinical outcomes and well being while reducing healthcare systems and payors' financial burden.
NEW YORK, Feb. 12, 2025 /PRNewswire/ --QuantalX Neuroscience Ltd. is proud to announce that its groundbreaking brain health assessment device, the Delphi-MD, has received CE MDR approval, the European Union's certification under the new Medical Device Regulation (MDR). The CE MDR certification process sets a new benchmark for safety, efficacy, and quality in medical devices. This achievement underscores QuantalX's commitment to innovation and excellence in neurological care.
More Post from the Author
- AutoMobility LA 2025
- Radiate Holdco, LLC Releases Third Quarter 2025 Financial Results
- Workshop Debuts Four New AI Features, Positioning Itself as the Clear Leader in AI for Internal Communications
- r4 Technologies Donates Smart Food AI Program to Help States Feed SNAP Beneficiaries
- Armor Health's Data Driven Approach to Patient Care Helps Secure Agreement to Provide Correctional Healthcare Service for Inmates in Bell County Texas